Skip to Content
MilliporeSigma
  • Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.

Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.

Journal of veterinary pharmacology and therapeutics (2017-04-30)
S Gharibi, B Kimble, L Vogelnest, J Barnes, C K Stadler, M Govendir
ABSTRACT

The pharmacokinetic profile of posaconazole in clinically normal koalas (n = 8) was investigated. Single doses of posaconazole were administered intravenously (i.v.; 3 mg/kg; n = 2) or orally (p.o.; 6 mg/kg; n = 6) with serial plasma samples collected over 24 and 36 hr, respectively. Plasma concentrations of posaconazole were quantified by validated high-performance liquid chromatography. A noncompartmental pharmacokinetic analysis of data was performed. Following i.v. administration, estimates of the median (range) of plasma clearance (CL) and steady-state volume of distribution (V

MATERIALS
Product Number
Brand
Product Description

Supelco
Posaconazole, VETRANAL®, analytical standard